BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance
Summary
BrightSpring Health Services reported robust fourth quarter and full year 2025 financial results, significantly exceeding prior year performance. For Q4 2025, net revenue increased 29.3% to $3,551 million, and net income surged to $49.6 million from $4.3 million in Q4 2024. Full year 2025 saw net revenue grow 28.2% to $12,911 million, with the company swinging to a net income of $104.8 million from a net loss of $68.9 million in 2024. Adjusted EBITDA also showed strong growth, up 40.7% for the quarter and 34.2% for the full year, alongside a notable improvement in leverage from 4.16x to 2.99x. The company also initiated full year 2026 guidance and repurchased $43.2 million in shares. These strong results, including significant profitability and leverage improvements, indicate solid operational execution and financial health, likely reinforcing investor confidence, especially as the stock trades near its 52-week high. Traders will be watching the market's reaction to the specific 2026 guidance and the upcoming divestiture of the Community Living business.
At the time of this announcement, BTSG was trading at $40.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.2B. The 52-week trading range was $15.48 to $41.40. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.